Skip to main content

AMCP Nexus 2025 Posters Main banner

Mental Health

Mental Health

Type here to filter the list

(265) Effect of Antihypertensive Medications on Economic Burden Among Alzheimer’s Disease and Related Dementia (ADRD): ADRD Registry Data linked to Medicaid
(266) Dosing to effect with weekly and monthly subcutaneous buprenorphine: post-hoc analysis of a Phase 3, open-label study
(267) Post-launch adverse events reported to FDA adverse event reporting system for long-acting injectable buprenorphine
(268) Economic impact of experiential negative symptoms among patients living with schizophrenia: Medical expenditure panel survey
(269) Healthcare resource utilization and costs of schizophrenia among Medicaid beneficiaries
(270) Indirect treatment comparison of somnolence or sedation with dopamine partial agonists versus D2 receptor antagonists in major depressive disorder and schizophrenia
(271) Discontinuation of long-acting injectable versus oral antipsychotics in US patients with schizophrenia: a new-user survival analysis
(272) Risk factors for post-injury mental health conditions: A retrospective cohort study using the Cox proportional hazards model.
(273) Assessment of the impact of physical injuries on mental health among commercially insured workers’ compensation beneficiaries.
(274) Treatment patterns and healthcare resource utilization in patients with schizophrenia or bipolar I disorder in the 6 months following initiation of olanzapine/samidorphan versus other atypical antipsychotics
(275) Healthcare resource utilization and cost among commercially insured opioid use disorder patients treated with monthly injectable buprenorphine: a retrospective claims analysis
(276) Healthcare resource utilization among patients with opioid use disorder insured by Medicaid and treated with monthly injectable buprenorphine: a retrospective claims analysis
(277) Impact of Manufacturer Coupon Use on Product Switching in Major Depressive Disorder (MDD) Treatment
(278) Socioeconomic Vulnerabilities and Postpartum Depression: Assessing the Aftermath of Dobbs v. Jackson in Trigger and Non-Trigger States
(279) The Impact of Extreme Heat on Mental Health Utilization and Prescriptions
(280) An economic model assessing costs, relapses, and antipsychotic adherence of switching Medicaid beneficiaries with schizophrenia from oral antipsychotics to once-monthly, once-every-three-months, and once-every-six-months paliperidone palmitate